PYXSPyxis Oncology, Inc.vs its industry peers
A metric-by-metric comparison of Pyxis Oncology, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PYXSEsta | $280M#7 | — | 24.5x#10 | 20.2x#7 | -14.2%#9 | -3.0%#5 | -609.2%#7 | -696.0%#12 | — | — | 45.5%#5 | — |
| ABEO | $321M#1 | — | 2.5x#7 | 55.1x#8 | — | -211.7%#12 | -1536.9%#10 | -55.6%#7 | -121.6%#1 | — | -0.4%#9 | — |
| CTNM | $316M#2 | — | 1.3x#5 | — | -100.0%#12 | -41.9%#9 | — | -25.0%#4 | — | — | 10.2%#8 | — |
| VNDA | $307M#3 | — | 1.4x#6 | 1.4x#2 | 8.7%#7 | -1066.7%#15 | -70.0%#3 | -100.1%#9 | — | — | 12.5%#7 | — |
| CUE | $293M#4 | — | 126.7x#12 | 10.7x#6 | 195.7%#2 | 34.6%#2 | -96.7%#4 | -1151.6%#13 | — | — | 82.3%#2 | — |
| UPB | $292M#5 | — | 1.1x#2 | 102.5x#10 | 20.4%#6 | -128.4%#11 | -5618.8%#11 | -52.9%#6 | — | — | -69.0%#14 | — |
| FULC | $288M#6 | — | 0.9x#1 | — | -100.0%#12 | -670.0%#14 | — | -24.1%#3 | — | — | -49.9%#13 | — |
| GLSI | $275M#8 | — | 88.4x#11 | — | — | -11.2%#6 | — | -621.1%#11 | — | — | 62.9%#3 | — |
| TRDA | $268M#9 | — | 1.1x#4 | 10.6x#5 | -87.9%#11 | -319.0%#13 | -621.1%#8 | -61.6%#8 | — | — | 24.1%#6 | — |
| MGNX | $261M#10 | — | 6.1x#8 | 1.7x#3 | -0.3%#8 | -11.4%#7 | -48.7%#2 | -0.2%#1 | — | — | 137.4%#1 | — |
| LYEL | $260M#11 | — | 1.1x#3 | 7222.2x#11 | -41.0%#10 | 20.0%#3 | -748344.4%#12 | -117.4%#10 | — | — | -15.5%#10 | — |
| BCYC | — | — | — | — | 105.8%#3 | -29.5%#8 | -340.4%#6 | -42.9%#5 | -794.1%#2 | — | -48.8%#12 | — |
| CAMP | $253M#12 | — | — | 72.2x#9 | 436.5%#1 | -55.2%#10 | -1502.4%#9 | — | — | — | 60.0%#4 | — |
| AKBA | $247M#13 | — | 9.9x#9 | 1.0x#1 | 47.5%#4 | 92.4%#1 | 9.9%#1 | -21.2%#2 | — | — | -70.0%#15 | — |
| FHTX | $246M#14 | — | — | 8.0x#4 | 36.8%#5 | 14.2%#4 | -279.5%#5 | — | — | — | -19.6%#11 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice